Literature DB >> 7280620

[Sudden cardiac death due to conduction disorder. III. Is the so-called idiopathic AV block caused by a congenital abnormality?].

J Schneider.   

Abstract

The aim of this third part is to discuss the nature and origin of the destructive lesion of the conduction system. A total of 53 hearts of patients dying from av-block was available for this study, and in morbid anatomy the commonest pattern of lesions responsible for av-block is destruction of the branching bundle and the origin of both bundle branches. The pathological processes found in the heart and conduction system are as follows: ischemic heart disease (49%), surgical lesions (15%), calcificatory destruction (6%), inflammatory destruction (6%), various distinct causes (11%), and primary av-block (13%). Main interest is focused on the group with primary heart block. Morphologically our series shows little fibrosis but an unexplained loss of conduction fibers and strikingly atrophic elements (filiform fibers). At attempt is made to explain the loss of conduction fibers as a consequence of the natural developing process which separates the atria from the ventricles, a separation essential for electrical stability of the heart. It is accepted that the accessory muscle bundles which characterize the Wolff-Parkinson-White syndrome are a failure in reduction of the muscle fibers running from the atria to the ventricles at an early embryological stage. If this same process runs to excess, the result must be an av-block. We consider a part of the so-called primary av-block to be a consequence of this process.

Entities:  

Mesh:

Year:  1981        PMID: 7280620

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


  1 in total

1.  Histologic spectrum of the cardiac conducting tissue in non-natural deaths under 30 years of age: an analysis of 43 cases with special implications for sudden cardiac death.

Authors:  Fred Zack; Ann-Katrin Rodewald; Verena Blaas; Andreas Büttner
Journal:  Int J Legal Med       Date:  2015-11-02       Impact factor: 2.686

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.